Skip to content

Latest disclosed trades

Every stock trade disclosed by members of Congress, the executive branch and company insiders — newest first.

See the trades

Updated Oct 29 · 2 feeds behind: Congress trades, 18 days, and 1 more · Every feed →

All 10Congress 0Executive branch 0Insiders 10
AllBuysSells
Filed late
More filters
DemRepInd
HouseSenateExecutive
$15K+$50K+$100K+$250K+$1M+
Clear filters

CTNM · 10 trades

Trades
10
Buys 0 · Sells 10
People
3
Stocks
1
Disclosed value
$1.1M
range midpoints · Congress & executive
Filed late
0
  1. ▼ SELLCarmine N. Stengone CEO and PresidentCTNM Contineum Therapeutics, Inc.$41.1Kdisclosed Sep 8 · filed the same day
  2. ▼ SELLCarmine N. Stengone CEO and PresidentCTNM Contineum Therapeutics, Inc.$40Kdisclosed Aug 3 · filed the same day
  3. ▼ SELLDaniel S. Lorrain Chief Scientific OfficerCTNM Contineum Therapeutics, Inc.$400disclosed Jul 10 · filed 1 day after the trade
  4. ▼ SELLDaniel S. Lorrain Chief Scientific OfficerCTNM Contineum Therapeutics, Inc.$16.2Kdisclosed Jul 10 · filed 2 days after the trade
  5. ▼ SELLCarmine N. Stengone CEO and PresidentCTNM Contineum Therapeutics, Inc.$40Kdisclosed Jul 8 · filed the same day
  6. ▼ SELLDaniel S. Lorrain Chief Scientific OfficerCTNM Contineum Therapeutics, Inc.$40.6Kdisclosed Jul 2 · filed 1 day after the trade
  7. ▼ SELLDaniel S. Lorrain Chief Scientific OfficerCTNM Contineum Therapeutics, Inc.$91.7Kdisclosed Jul 2 · filed 1 day after the trade
  8. ▼ SELLDaniel S. Lorrain Chief Scientific OfficerCTNM Contineum Therapeutics, Inc.$462Kdisclosed Jul 2 · filed 2 days after the trade
  9. ▼ SELLCarmine N. Stengone CEO and PresidentCTNM Contineum Therapeutics, Inc.$160Kdisclosed Jul 1 · filed 1 day after the trade
  10. ▼ SELLTim Watkins CMO & Head of DevelopmentCTNM Contineum Therapeutics, Inc.$174Kdisclosed Jul 1 · filed 1 day after the trade